World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
44571
World Ranking
10293
National Ranking
5295

Overview

Gary R. Lichtenstein is affiliated with the University of Pennsylvania in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant work in subfields including Genetics, Epidemiology, Surgery, Immunology, and Oncology.

The scientist's work extensively covers topics related to Inflammatory Bowel Disease, Microscopic Colitis, Immunodeficiency and Autoimmune Disorders, Eosinophilic Esophagitis, Helicobacter pylori-related gastroenterology studies, Diagnosis and treatment of tuberculosis, and Diverticular Disease and Complications.

Frequent publication venues for Gary R. Lichtenstein include Gastroenterology, The American Journal of Gastroenterology, Inflammatory Bowel Diseases, Journal of Crohn's and Colitis, and Digestive Diseases and Sciences.

Frequent co-authors collaborating with Lichtenstein are:

  • Abhik Bhattacharya (15 works)
  • Mark T. Osterman (14 works)
  • Bhavana Bhagya Rao (11 works)
  • James D. Lewis (10 works)
  • Daniel Travis (8 works)

Recent papers authored or co-authored by Gary R. Lichtenstein include:

  • ACG Clinical Guideline: Management of Crohn's Disease in Adults, 2025, The American Journal of Gastroenterology
  • Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan® Administrative Claims Database With Tofacitinib Trial Data, 2020, Inflammatory Bowel Diseases
  • Medical, Political, and Economic Considerations for the Use of MAC for Endoscopic Sedation: Big Price, Little Justification?, 2020, Digestive Diseases and Sciences
  • A Multimodal Intervention Using Nonopioid Analgesics Is Associated With Reduced Intravenous Opioid Exposure Among Hospitalized Patients With Inflammatory Bowel Diseases, 2020, The American Journal of Gastroenterology
  • Care of immunocompromised patients with head and neck cancer during the COVID-19 pandemic: Two challenging and informative clinical cases, 2020, Head & Neck

Best Publications

  • Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

    Stephen B Hanauer;Brian G Feagan;Gary R Lichtenstein;Lloyd F Mayer

  • Infliximab for induction and maintenance therapy for ulcerative colitis.

    Paul Rutgeerts;William J Sandborn;Brian G Feagan;Walter Reinisch

  • Management of Crohn's Disease in Adults

    Gary R Lichtenstein;Stephen B Hanauer;Stephen B Hanauer;Stephen B Hanauer;William J Sandborn;William J Sandborn;William J Sandborn

  • Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.

    Paul Rutgeerts;Brian G. Feagan;Gary R. Lichtenstein;Lloyd F. Mayer

  • ACG Clinical Guideline: Management of Crohn’s Disease in Adults

    Gary R Lichtenstein;Edward V Loftus;Kim L Isaacs;Miguel D Regueiro

  • Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry

    Gary R. Lichtenstein;Brian G. Feagan;Russell D. Cohen;Bruce A. Salzberg

  • Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

    Jean Frédéric Colombel;Paul Rutgeerts;Walter Reinisch;Dirk Esser

  • Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis

    James D. Lewis;Shaokun Chuai;Lisa Nessel;Gary R. Lichtenstein

  • Serious Infection and Mortality in Patients With Crohn ' s Disease: More Than 5 Years of Follow-Up in the TREAT ™ Registry

    Gary R Lichtenstein;Brian G Feagan;Russell D Cohen;Bruce A Salzberg

  • Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn’s disease

    Gary R. Lichtenstein;Songkai Yan;Mohan Bala;Marion Blank

  • Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease

    Paul Rutgeerts;Robert H. Diamond;Mohan Bala;Allan Olson

  • Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

    Simon P L Travis;Dan Schnell;Piotr Krzeski;Maria T Abreu

  • American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease

    Gary R. Lichtenstein;Maria T. Abreu;Russell Cohen;William Tremaine

  • Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab

    William J. Sandborn;Paul Rutgeerts;Brian G. Feagan;Walter Reinisch

  • Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid Arthritis

    Jeffry A Katz;Christian Antoni;Gregory F Keenan;Deirdre E Smith

  • A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease.

    David S. Kotlyar;Mark T. Osterman;Robert H. Diamond;David Porter

  • ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.

    Francis A Farraye;Gil Y Melmed;Gary R Lichtenstein;Sunanda V Kane

  • Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis.

    Mark T. Osterman;Rabi Kundu;Gary R. Lichtenstein;James D. Lewis

  • Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity

    Simon P.L. Travis;Dan Schnell;Piotr Krzeski;Maria T. Abreu

  • Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.

    David S. Kotlyar;David S. Kotlyar;James D. Lewis;Laurent Beaugerie;Ann Tierney

Frequent Co-Authors

James D. Lewis
James D. Lewis University of Pennsylvania
William J. Sandborn
William J. Sandborn University of California, San Diego
Brian G. Feagan
Brian G. Feagan University of Western Ontario
Stephen B. Hanauer
Stephen B. Hanauer Northwestern University
Edward V. Loftus
Edward V. Loftus Mayo Clinic
Stefan Schreiber
Stefan Schreiber Kiel University
Michael A. Kamm
Michael A. Kamm University of Melbourne
Jean-Frederic Colombel
Jean-Frederic Colombel Icahn School of Medicine at Mount Sinai
Bruce E. Sands
Bruce E. Sands Icahn School of Medicine at Mount Sinai
Walter Reinisch
Walter Reinisch Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While studying Medicine in the USA often means pursuing a traditional medical degree, there are alternative online pathways for those interested in the healthcare field. For students wanting to enter the workforce quickly, fast track lpn programs provide an accelerated route to become a Licensed Practical Nurse.

For nurses who want to specialize in mental health, online pmhnp programs offer flexible studies that lead to advanced roles as Psychiatric Mental Health Nurse Practitioners. These programs are ideal for registered nurses seeking in-depth expertise and job growth.

If healthcare leadership and management appeal to you, pursuing a Master of Healthcare Administration (MHA) can unlock administrative and executive opportunities. You can explore the best online mha programs for comprehensive, accredited studies. Concerned about finances? Check out the cheapest online mha options to maximize the value of your investment.

Best Scientists Citing Gary R. Lichtenstein

Trending Scientists

Recently Published Articles